M
Magenta Therapeutics Inc
F:3MT
Magenta Therapeutics Inc
F:3MT
Price:
11.136
EUR
0.29%
Market Cap:
€368.6m
Income Statement
Earnings Waterfall
Magenta Therapeutics Inc
Magenta Therapeutics Inc
Income Statement
Magenta Therapeutics Inc
Magenta Therapeutics Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(36)
|
(60)
|
(83)
|
|
| Selling, General & Administrative |
(8)
|
(19)
|
(24)
|
|
| Research & Development |
(28)
|
(41)
|
(59)
|
|
| Operating Income |
(36)
N/A
|
(60)
-68%
|
(83)
-38%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
2
|
6
|
|
| Pre-Tax Income |
(35)
N/A
|
(58)
-62%
|
(77)
-33%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
0
|
|
| Income from Continuing Operations |
(35)
|
(58)
|
(77)
|
|
| Net Income (Common) |
(36)
N/A
|
(58)
-62%
|
(77)
-33%
|
|
| EPS (Diluted) |
-16.53
N/A
|
-50.12
-203%
|
-33.18
+34%
|
|
Switch to:
Switch to:
See Also
Discover More
